Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA selenocysteine 1-associated protein 1 (TRNAU1AP) is a protein encoded by the TRNAU1AP gene, mainly involved in the early stages of selenocysteine biosynthesis and the specific charging of selenocysteine tRNA (tRNA(Sec)). This process is essential for the co-translational incorporation of selenocysteine into selenoproteins during translation. The protein stabilizes a complex containing SECISBP2, EEFSEC, and tRNA(Sec), which is necessary for efficient selenoprotein synthesis and may also be involved in tRNA(Sec) methylation[1][2][6]. TRNAU1AP is predicted to be found in the cytoplasm and nucleus and displays RNA binding activity. Disruption or variation in TRNAU1AP is associated with rare metabolic disease (Combined D-2- and L-2-hydroxyglutaric aciduria), but no direct involvement in common diseases, no known drugs, and no therapeutic targeting have been established[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA selenocysteine 1-associated protein 1 (TRNAU1AP).